CD146 As a Prognostic-Related Biomarker in CcRCC Correlating With Immune Infiltrates

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Dec 27

PMID 34956870

Citations 7

Authors

Zheng Lv

Hua-Yi Feng

Wang Tao

Hong-Zhao Li

Xu Zhang

Affiliations

Soon will be listed here.

Abstract

Backgrounds: CD146 is highly expressed in various malignant tumors and associated with the poor prognosis. However, the role of CD146 in clear cell renal cell carcinoma (ccRCC) is still unknown. This study aimed to identify the role of CD146 in ccRCC by integrated bioinformatics analysis.

Methods: CD146 mRNA expression and methylation data in ccRCC was examined using the TIMER, UALCAN, and MethSurv databases. CD146 expression in paraffin-embedded tissues (140 cancer samples and 140 paracancer tissues) from our cohort were examined by immunohistochemistry assay. The LinkedOmics database was used to study the signaling pathways related to CD146 expression. TIMER and TISIDB were used to analyze the correlations among CD146, CD146-coexpressed genes, tumor-infiltrating immune cells, and immunomodulators. The relationship between CD146 and drug response in renal cancer cell lines was analyzed by the CTRP and CCLE databases.

Results: The mRNA and protein levels of CD146 were elevated in ccRCC tissues than that in paracancer tissues. The DNA methylation of CD146 in ccRCC tissues were lower than that in normal tissues. Importantly, high CD146 expression was associated with poor prognosis in patients with ccRCC. Furthermore, multivariate Cox regression analysis showed that CD146 was an independent prognostic factor in ccRCC. GO and KEGG pathway analyses indicated the co-expressed genes of CD146 were mainly related to a variety of immune-related pathways, including Th1 and Th2 cell differentiation, Th17 cell differentiation, and leukocyte transendothelial migration. Our data demonstrated that the expression and methylation status of CD146 were strongly correlated with immune infiltration levels, immunomodulators, and chemokines. Further, the sensitivity and resistance of renal cancer cell lines to some drugs were related to CD146 expression.

Conclusions: Our study highlights the clinical significance of CD146 in ccRCC and provides novel insights into the immune function of CD146 in the tumor microenvironment.

Citing Articles

Melanoma Cell Adhesion Molecule Plays a Pivotal Role in Proliferation, Migration, Tumor Immune Microenvironment, and Immunotherapy in Colorectal Cancer.

Zhou J, Liu J, Yu Y, Nie H, Hong Y, Ning Y Cancer Med. 2025; 14(5):e70740.

PMID: 40042109 PMC: 11880918. DOI: 10.1002/cam4.70740.

Melanoma Cell Adhesion Molecule (CD 146) in Endometrial Physiology and Disorder.

Hilage P, Damle M, Sharma R, Joshi M Adv Exp Med Biol. 2024; 1474():131-148.

PMID: 39400880 DOI: 10.1007/5584_2024_826.

Netrin-1-CD146 and netrin-1-S100A9 are associated with early stage of lymph node metastasis in colorectal cancer.

Chen J, He J, Qiu J, Yang G, Wang D, Shen Z BMC Gastroenterol. 2024; 24(1):308.

PMID: 39261771 PMC: 11389491. DOI: 10.1186/s12876-024-03401-w.

Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.

Li Q, Guo Q, Luo W, Luo X, Ji Y, Xu L Aging (Albany NY). 2024; 16(1):66-88.

PMID: 38170222 PMC: 10817379. DOI: 10.18632/aging.205338.

CD146-targeted nuclear medicine imaging in cancer: state of the art.

Yang Q, Huang W, Hsu J, Song L, Sun X, Li C View (Beijing). 2023; 4(5).

PMID: 38076327 PMC: 10703309. DOI: 10.1002/VIW.20220085.

References

Lee A, Lee H, Huang H, Tay K, Lee L, Sim S . Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2020; 18(4):304-313. DOI: 10.1016/j.clgc.2019.11.013. View

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Falagario U, Busetto G, Netti G, Sanguedolce F, Selvaggio O, Infante B . Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy. Cancers (Basel). 2021; 13(7). PMC: 8036446. DOI: 10.3390/cancers13071611. View

Huang Q, Ma X, Li H, Ai Q, Liu S, Zhang Y . Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis. Oncotarget. 2014; 5(10):3066-75. PMC: 4102792. DOI: 10.18632/oncotarget.1827. View

Dagur P, Tatlici G, Gourley M, Samsel L, Raghavachari N, Liu P . CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry B Clin Cytom. 2009; 78(2):88-95. PMC: 2904479. DOI: 10.1002/cyto.b.20502. View

Murata M . Inflammation and cancer. Environ Health Prev Med. 2018; 23(1):50. PMC: 6195709. DOI: 10.1186/s12199-018-0740-1. View

Paner G, Stadler W, Hansel D, Montironi R, Lin D, Amin M . Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol. 2018; 73(4):560-569. DOI: 10.1016/j.eururo.2017.12.018. View

Sousa S, Maatta J . The role of tumour-associated macrophages in bone metastasis. J Bone Oncol. 2016; 5(3):135-138. PMC: 5063225. DOI: 10.1016/j.jbo.2016.03.004. View

Chen Y, Sumardika I, Tomonobu N, Kinoshita R, Inoue Y, Iioka H . Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness. Neoplasia. 2019; 21(7):627-640. PMC: 6520639. DOI: 10.1016/j.neo.2019.04.006. View

10.

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

11.

Schodel J, Grampp S, Maher E, Moch H, Ratcliffe P, Russo P . Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. Eur Urol. 2015; 69(4):646-657. PMC: 5012644. DOI: 10.1016/j.eururo.2015.08.007. View

12.

Guezguez B, Vigneron P, Lamerant N, Kieda C, Jaffredo T, Dunon D . Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol. 2007; 179(10):6673-85. DOI: 10.4049/jimmunol.179.10.6673. View

13.

Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y . KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. Cancer Res. 2016; 77(2):330-342. DOI: 10.1158/0008-5472.CAN-16-0348. View

14.

Miao D, Margolis C, Gao W, Voss M, Li W, Martini D . Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science. 2018; 359(6377):801-806. PMC: 6035749. DOI: 10.1126/science.aan5951. View

15.

Shih L, Hsu M, Palazzo J, Herlyn M . The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol. 1997; 151(3):745-51. PMC: 1857834. View

16.

Sun Z, Ji N, Ma Q, Zhu R, Chen Z, Wang Z . Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis. Front Immunol. 2020; 11:1598. PMC: 7387705. DOI: 10.3389/fimmu.2020.01598. View

17.

Choueiri T, Halabi S, Sanford B, Hahn O, Michaelson M, Walsh M . Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial. J Clin Oncol. 2017; 35(6):591-597. PMC: 5455807. DOI: 10.1200/JCO.2016.70.7398. View

18.

Mukaka M . Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2013; 24(3):69-71. PMC: 3576830. View

19.

Dudzik P, Trojan S, Ostrowska B, Lasota M, Dulinska-Litewka J, Laidler P . Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression. Acta Biochim Pol. 2019; 66(4):619-625. DOI: 10.18388/abp.2019_2907. View

20.

Danaher P, Warren S, Dennis L, DAmico L, White A, Disis M . Gene expression markers of Tumor Infiltrating Leukocytes. J Immunother Cancer. 2017; 5:18. PMC: 5319024. DOI: 10.1186/s40425-017-0215-8. View